Joint Site May Influence RA Treatment Response

A Swiss registry study found that the wrist and second and third metacarpophalangeal joints consistently resolved more slowly than most other joints following biologic or targeted synthetic therapy.

By
Andrea Surnit
July 15, 2026
4 min

MDSpire News

Original Source(s)

Mdspire News

Joint Site May Influence RA Treatment Response

by Andrea Surnit
July 15, 2026

Related Content

Frontiers In Immunology

TNFAIP3/A20 dysfunction drives innate and sterile hyperinflammation

by Karel F. A. Van Damme, Pieter Hertens, Dorine Sichien, Katrien Van der Borght, Justine Van Moorleghem, Sofie De Prijck, Alex Klarenbeek, Els Louagie, Inés Lammens, Stijn Vanhee, Christian Vanhove, Pieter De Bleser, Steven Van Laecke, Amélie Dendooven, Hamida Hammad, Lars Vereecke, Dirk Elewaut, Geert van Loo, Bart N. Lambrecht
July 17, 2026

Arthritis & Rheumatology

Autoantibodies to Joint-Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals

by Outi Sareila, Linda Johansson, Anders Lundquist, Monica Leu Agelii, Lei Cheng, Yibo He, Erik Lönnblom, Maria Andersson, Jan Kihlberg, Anders Esberg, Inger Gjertsson, Rikard Holmdahl, Solbritt Rantapää-Dahlqvist
May 27, 2026

MDSpire News

RA Outcomes Improved in KURAMA Cohort

Ten-year observational data showed lower disease activity and functional disability coinciding with broader use of biologic and targeted synthetic therapies.

by Andrea Surnit
May 22, 2026
4 min